文献速递免疫规划卫生政策与健康促进

挪威多种疫苗可预防疾病的免疫缺口

Immunity gaps for several vaccine preventable diseases in Norway.
PubMed 文献 · Vaccine · 2026-07-07

该研究检测2012年挪威2-95岁人群3051份残余血清中7种疫苗可预防疾病的IgG水平,发现儿童和≥60岁人群白喉、破伤风抗体不足,百日咳抗体也普遍低于 suggested 阈值;麻疹和风疹各年龄组IgG充足,腮腺炎接近保护阈值。结论提示需调整DTP加强针时间并将DTP纳入成人免疫规划。

要点

  • ≥60岁人群白喉和破伤风IgG低于保护阈值比例高,女性尤为明显。
  • 6岁儿童白喉和破伤风IgG低水平比例分别为20.7%和25.0%。
  • 6岁儿童76.4%百日咳毒素IgG低于5 IU/ml suggested 保护阈值。

核心结论

  • 儿童和60岁以上人群白喉、破伤风IgG水平低,百日咳抗体也普遍低于 suggested 阈值。
  • 研究结果支持调整儿童免疫规划中DTP加强针时间并将DTP疫苗纳入成人接种计划。

研究设计与样本

  • 检测2012年挪威2-95岁人群3051份残余血清中7种疫苗可预防疾病的IgG水平。

主要发现

  • 1952年儿童免疫规划启动前出生(≥60岁)的女性39.8%、男性25.0%白喉IgG低于保护阈值。
  • 同人群女性76.5%、男性41.7%破伤风IgG低于保护阈值。
  • 6岁儿童20.7%白喉IgG低水平,25.0%破伤风IgG低水平。
  • 以5 IU/ml为百日咳毒素IgG suggested 保护阈值,6岁儿童76.4%、16岁青少年53.3%、≥60岁人群32.3%低于该水平。
  • 麻疹和风疹各年龄组IgG充足,腮腺炎IgG接近 suggested 保护阈值;麻疹、腮腺炎、风疹IgG最高见于40岁以上成人。

关键数值与推荐

  • 白喉和破伤风采用保护阈值判定IgG低水平。
  • 百日咳毒素IgG suggested 保护阈值为5 IU/ml。

临床怎么用

  • 应关注儿童和≥60岁人群白喉、破伤风及百日咳的免疫缺口。
  • 可考虑调整儿童免疫规划中DTP加强针时间并将DTP疫苗纳入成人接种计划。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Childhood immunisation programs (CIP) have led to a substantial reduction in vaccine preventable diseases. However, simply monitoring a decline in disease incidence does not accurately reflect an individual's immunity to each disease. To identify the immune status in the Norwegian population, we measured the IgG levels against antigens of 7 vaccine preventable diseases (diphtheria, tetanus, pertussis (DTP), measles, mumps, rubella and Hemophilus influenzae type b infection) in 3051 residual sera representative of the Norwegian population aged 2-95 years in 2012. We found that 39.8% of women and 25.0% of men born before the launch of the CIP in 1952 (i.e. ≥60 years) had IgG antibody levels below the protective threshold for diphtheria, and 76.5% and 41.7% for tetanus, respectively. Among children, 20.7% had low IgG levels against diphtheria and 25.0% had low levels against tetanus at age six years, prior to the DTP booster dose at age seven. When we applied a suggested cutoff for protection of 5 IU/ml for IgG antibodies against pertussis toxin, 76.4% of children aged 6 years fell below this level, as did about 53.3% of teenagers aged 16 years, and 32.3% of individuals aged 60 year or older. For measles and rubella, we found adequate levels of IgG in all age groups, whereas IgG levels against mumps were close to a suggested threshold for protection. The highest IgG levels for measles, mumps and rubella were observed in adults from the age of 40 years, most of whom have likely experienced the diseases and have probably never been vaccinated. In conclusion, we demonstrate low IgG levels against diphtheria and tetanus both in children and in individuals over 60 years of age. Our findings may be an argument for rescheduling of the DTP booster in the CIP and for including DTP vaccines in the adult vaccination program.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Aase A, Herstad TK, Greve-Isdahl M, et al. Immunity gaps for several vaccine preventable diseases in Norway. Vaccine. 2026. PMID: 42413320. doi:10.1016/j.vaccine.2026.128905

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。